Krystal Biotech, Inc. (KRYS) Earnings
NASDAQ·Healthcare·Biotechnology
$269.62
-1.15%
Mkt Cap $8.07B
Next Earnings
In 5 daysMon, May 4, 2026
EPS Estimate
$1.49
4 analysts
Revenue Estimate
$112.48M
Last quarter: beat by +4.94% on EPS, +1.67% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$8.07B
P/E
39.82
Fwd P/E
34.15
P/S
20.73
Rev TTM
—
EPS TTM
$6.85